https://scholars.lib.ntu.edu.tw/handle/123456789/631512
標題: | Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis | 作者: | Winters, Nicholas Belknap, Robert Benedetti, Andrea Borisov, Andrey Campbell, Jonathon R Chaisson, Richard E Chan, Pei-Chun Martinson, Neil Nahid, Payam Scott, Nigel A Sizemore, Erin Sterling, Timothy R Villarino, M Elsa JANN-YUAN WANG Menzies, Dick |
公開日期: | 23-三月-2023 | 來源出版物: | The Lancet. Respiratory medicine | 摘要: | 3 months of weekly rifapentine plus isoniazid (3HP) and 4 months of daily rifampicin (4R) are recommended for tuberculosis preventive treatment. As these regimens have not been compared directly, we used individual patient data and network meta-analysis methods to compare completion, safety, and efficacy between 3HP and 4R. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/631512 | ISSN: | 22132600 | DOI: | 10.1016/S2213-2600(23)00096-6 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。